Cargando…

Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis

BACKGROUND: Introduction of human papillomavirus (HPV) vaccination has been slow in low-income and middle-income countries (LMICs) because of resource constraints and worldwide shortage of vaccine supplies. To help inform WHO recommendations, we modelled various HPV vaccination strategies to examine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drolet, Mélanie, Laprise, Jean-François, Martin, Dave, Jit, Mark, Bénard, Élodie, Gingras, Guillaume, Boily, Marie-Claude, Alary, Michel, Baussano, Iacopo, Hutubessy, Raymond, Brisson, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science ;, The Lancet Pub. Group 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554391/ https://www.ncbi.nlm.nih.gov/pubmed/34245682 http://dx.doi.org/10.1016/S1473-3099(20)30860-4

Ejemplares similares

Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysis
por: Bénard, Élodie, et al.
Publicado: (2022)

Potential population-level effectiveness of one-dose HPV vaccination in low-income and middle-income countries: a mathematical modelling analysis
por: Bénard, Élodie, et al.
Publicado: (2023)

Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries
por: Brisson, Marc, et al.
Publicado: (2020)

Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries
por: Canfell, Karen, et al.
Publicado: (2020)

Mathematical Modeling of the Transmission Dynamics of Clostridium difficile Infection and Colonization in Healthcare Settings: A Systematic Review
por: Gingras, Guillaume, et al.
Publicado: (2016)

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models
por: Jit, Mark, et al.
Publicado: (2011)

Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries
por: Levin, Ann, et al.
Publicado: (2023)

Upscaling human papillomavirus vaccination in high-income countries: impact assessment based on transmission model
por: Baussano, Iacopo, et al.
Publicado: (2014)

Vaccinating Girls and Boys with Different Human Papillomavirus Vaccines: Can It Optimise Population-Level Effectiveness?
por: Drolet, Mélanie, et al.
Publicado: (2013)

Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts
por: Jit, Mark, et al.
Publicado: (2013)

Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis
por: Prem, Kiesha, et al.
Publicado: (2023)

Human Papillomavirus Vaccination at a Time of Changing Sexual Behavior
por: Baussano, Iacopo, et al.
Publicado: (2016)

From cervical cancer elimination to eradication of vaccine-type human papillomavirus: Feasibility, public health strategies and cost-effectiveness
por: Jit, Mark, et al.
Publicado: (2021)

Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries
por: Ochalek, Jessica, et al.
Publicado: (2020)

Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries
por: Deogaonkar, Rohan, et al.
Publicado: (2012)

Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model
por: Jit, Mark, et al.
Publicado: (2015)

Q&A - Economic analyses for vaccine introduction decisions in low- and middle- income countries
por: Hutubessy, Raymond
Publicado: (2013)

Evidence of synergistic relationships between HIV and Human Papillomavirus (HPV): systematic reviews and meta‐analyses of longitudinal studies of HPV acquisition and clearance by HIV status, and of HIV acquisition by HPV status
por: Looker, Katharine J, et al.
Publicado: (2018)

Stakeholders’ perception on including broader economic impact of vaccines in economic evaluations in low and middle income countries: a mixed methods study
por: van der Putten, Ingeborg M, et al.
Publicado: (2015)

Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Framework
por: Carvalho, Natalie, et al.
Publicado: (2017)

Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models
por: Brisson, Marc, et al.
Publicado: (2016)

The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study
por: Clark, Rebecca A, et al.
Publicado: (2023)

Impact and cost-effectiveness of measles vaccination through microarray patches in 70 low-income and middle-income countries: mathematical modelling and early-stage economic evaluation
por: Fu, Han, et al.
Publicado: (2023)

Impacts of human papillomavirus vaccination for different populations: A modeling study
por: Baussano, Iacopo, et al.
Publicado: (2018)

Vaccinating Women Previously Exposed to Human Papillomavirus: A Cost-Effectiveness Analysis of the Bivalent Vaccine
por: Turner, Hugo C., et al.
Publicado: (2013)

Screening for Human Papillomavirus in a Low- and Middle-Income Country
por: Atkinson, Aaron E., et al.
Publicado: (2019)

Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible?
por: Jit, Mark, et al.
Publicado: (2016)

Costs of Introducing and Delivering HPV Vaccines in Low and Lower Middle Income Countries: Inputs for GAVI Policy on Introduction Grant Support to Countries
por: Levin, Ann, et al.
Publicado: (2014)

Potential lives saved in 73 countries by adopting multi‐cohort vaccination of 9–14‐year‐old girls against human papillomavirus
por: Jit, Mark, et al.
Publicado: (2018)

Low Human Papillomavirus Vaccination in a Low-Income Urban Population
por: Rojo, Elizabeth M., et al.
Publicado: (2023)

Estimates of case-fatality ratios of measles in low-income and middle-income countries: a systematic review and modelling analysis
por: Portnoy, Allison, et al.
Publicado: (2019)

Food (In)Security in Rapidly Urbanising, Low-Income Contexts
por: Tacoli, Cecilia
Publicado: (2017)

Income security and infant health: Social context matters
por: Assari, Shervin, et al.
Publicado: (2022)

The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study
por: Portnoy, Allison, et al.
Publicado: (2023)

Human papillomavirus vaccine coverage in Rwanda: A population-level analysis by birth cohort
por: Sayinzoga, Felix, et al.
Publicado: (2020)

What works for human papillomavirus vaccine introduction in low and middle-income countries?
por: Howard, Natasha, et al.
Publicado: (2017)

Time trends in social contacts before and during the COVID-19 pandemic: the CONNECT study
por: Drolet, Mélanie, et al.
Publicado: (2022)

Rethinking health systems in the context of urbanisation: challenges from four rapidly urbanising low-income and middle-income countries
por: Elsey, Helen, et al.
Publicado: (2019)

The relationship between income and assets in farms and context of sustainable development
por: Grzelak, Aleksander
Publicado: (2022)

Population-level impact of an accelerated HIV response plan to reach the UNAIDS 90-90-90 target in Côte d’Ivoire: Insights from mathematical modeling
por: Maheu-Giroux, Mathieu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9ial6ghv5j8sbk8lhm85phb775